Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
Be 'active' in the market while NOT being tied to your desk.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | 0.89% | 179.94 | 1.2% | $613.29m | |
| CELG | Celgene Corporation | 1.37% | 77.66 | 1.2% | $573.03m | |
| GILD | Gilead Sciences, Inc. | 0.50% | 68.17 | 0.9% | $553.71m | |
| BIIB | Biogen Inc. | 1.45% | 283.75 | 1.2% | $528.19m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.21% | 295.31 | 2.6% | $309.20m | |
| ILMN | Illumina, Inc. | 0.34% | 271.73 | 3.5% | $236.17m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 0.45% | 156.98 | 1.9% | $231.45m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.74% | 118.13 | 2.0% | $223.26m | |
| A | Agilent Technologies, Inc. | -0.48% | 64.53 | 1.5% | $209.75m | |
| NKTR | Nektar Therapeutics | 1.04% | 82.80 | 6.0% | $200.36m | |
| INCY | Incyte Corporation | 0.02% | 66.57 | 2.5% | $176.67m | |
| SRPT | Sarepta Therapeutics, Inc. | -0.29% | 88.96 | 16.6% | $124.64m | |
| BMRN | BioMarin Pharmaceutical Inc. | 0.97% | 88.46 | 4.4% | $118.47m | |
| EXAS | Exact Sciences Corporation | -3.10% | 51.35 | 25.5% | $112.48m | |
| BLUE | Bluebird Bio, Inc. | 2.02% | 189.40 | 15.7% | $96.63m |
Company Profile
Minerva Neurosciences, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. The company's product portfolio includes MIN-101, MIN-117, MIN-202 and MIN-301. Minerva Neurosciences was founded by Rogerio Vivaldi Coelho on April 23, 2007 and is headquartered in Cambridge, MA.